Page last updated: 2024-09-04

ilmenite and tetracycline

ilmenite has been researched along with tetracycline in 1 studies

Compound Research Comparison

Studies
(ilmenite)
Trials
(ilmenite)
Recent Studies (post-2010)
(ilmenite)
Studies
(tetracycline)
Trials
(tetracycline)
Recent Studies (post-2010) (tetracycline)
3301921,5249773,656

Protein Interaction Comparison

ProteinTaxonomyilmenite (IC50)tetracycline (IC50)
90-kda heat shock protein beta HSP90 beta, partialHomo sapiens (human)22.4474
heat shock protein HSP 90-alpha isoform 2Homo sapiens (human)22.4474
tyrosine-protein phosphatase non-receptor type 7 isoform 2Homo sapiens (human)8.33
30S ribosomal protein S6Escherichia coli K-124.58
30S ribosomal protein S7Escherichia coli K-124.58
50S ribosomal protein L15Escherichia coli K-124.58
50S ribosomal protein L10Escherichia coli K-124.58
50S ribosomal protein L11Escherichia coli K-124.58
50S ribosomal protein L7/L12Escherichia coli K-124.58
50S ribosomal protein L19Escherichia coli K-124.58
50S ribosomal protein L1Escherichia coli K-124.58
50S ribosomal protein L20Escherichia coli K-124.58
50S ribosomal protein L27Escherichia coli K-124.58
50S ribosomal protein L28Escherichia coli K-124.58
50S ribosomal protein L29Escherichia coli K-124.58
50S ribosomal protein L31Escherichia coli K-124.58
50S ribosomal protein L31 type BEscherichia coli K-124.58
50S ribosomal protein L32Escherichia coli K-124.58
50S ribosomal protein L33Escherichia coli K-124.58
50S ribosomal protein L34Escherichia coli K-124.58
50S ribosomal protein L35Escherichia coli K-124.58
50S ribosomal protein L36Escherichia coli K-124.58
30S ribosomal protein S10Escherichia coli K-124.58
30S ribosomal protein S11Escherichia coli K-124.58
30S ribosomal protein S12Escherichia coli K-124.58
30S ribosomal protein S13Escherichia coli K-124.58
30S ribosomal protein S16Escherichia coli K-124.58
30S ribosomal protein S18Escherichia coli K-124.58
30S ribosomal protein S19Escherichia coli K-124.58
30S ribosomal protein S20Escherichia coli K-124.58
30S ribosomal protein S2Escherichia coli K-124.58
30S ribosomal protein S3Escherichia coli K-124.58
30S ribosomal protein S4Escherichia coli K-124.58
30S ribosomal protein S5Escherichia coli K-124.58
30S ribosomal protein S8Escherichia coli K-124.58
30S ribosomal protein S9Escherichia coli K-124.58
50S ribosomal protein L13Escherichia coli K-124.58
50S ribosomal protein L14Escherichia coli K-124.58
50S ribosomal protein L16Escherichia coli K-124.58
50S ribosomal protein L23Escherichia coli K-124.58
30S ribosomal protein S15Escherichia coli K-124.58
50S ribosomal protein L17Escherichia coli K-124.58
50S ribosomal protein L21Escherichia coli K-124.58
50S ribosomal protein L30Escherichia coli K-124.58
50S ribosomal protein L6Escherichia coli K-124.58
30S ribosomal protein S14Escherichia coli K-124.58
30S ribosomal protein S17Escherichia coli K-124.58
30S ribosomal protein S1Escherichia coli K-124.58
50S ribosomal protein L18Escherichia coli K-124.58
Alpha-synucleinHomo sapiens (human)6.06
50S ribosomal protein L2Escherichia coli K-124.58
50S ribosomal protein L3Escherichia coli K-124.58
50S ribosomal protein L24Escherichia coli K-124.58
50S ribosomal protein L4Escherichia coli K-124.58
50S ribosomal protein L22Escherichia coli K-124.58
50S ribosomal protein L5Escherichia coli K-124.58
30S ribosomal protein S21Escherichia coli K-124.58
50S ribosomal protein L25Escherichia coli K-124.58
50S ribosomal protein L36 2Escherichia coli K-124.58

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Aggarwal, R; Chiu, N; Cui, J; Guo, Y; He, H; Ji, Q; Jusoh, N; Li, S; Liu, C; Liu, Y; Mazlan, N; Qi, C; Shi, Z; Song, H; Song, Y; Sow Mun Lock, S; Sun, D; Sun, S; Wadhera, RK; Wang, X; Xu, C; Yang, B; Yang, M; Yang, Q; Yang, S; Yang, X; Yun, D1

Other Studies

1 other study(ies) available for ilmenite and tetracycline

ArticleYear
    JAMA health forum, 2022, Volume: 3, Issue:7

    Topics: Aged; Anti-Bacterial Agents; Benzene Derivatives; Bismuth; Carbon Dioxide; Catalysis; Cohort Studies; Environmental Pollutants; Flame Retardants; Gases; Greenhouse Gases; Hospitals; Humans; Iron; Light; Medicare; Methane; Organophosphates; Oxidation-Reduction; Patient Care; Phosphates; Polymers; Reproducibility of Results; Tetracycline; Titanium; Ultraviolet Rays; United States; Value-Based Purchasing; Waste Disposal Facilities; Water Pollutants, Chemical

2022